Ray Dalio's position in Abbvie is currently worth $102 Million. That's 0.56% of their equity portfolio (39th largest holding). The first Abbvie trade was made in Q4 2020. Since then Ray Dalio bought shares eight more times and sold shares on four occasions. The stake costed the investor $88.6 Million, netting the investor a gain of 15% so far.